MF
Michael J. Farrell
Chairman and CEODirector

Michael J. Farrell insider trades: Resmed (RMD) stock buys and sales

Chairman and CEO, Resmed Last trade Oct 7, 2026 212 Form 4 filings
$12.2M
Sold, last 12 months
10 sales
$0
Bought, last 12 months
0 buys
104
Open-market trades
since 2010
3
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Michael reports to the SEC

Open-market buys and sales

104 trades reported on SEC Form 4, newest first

DateStockTypeValue
Oct 7, 2026RMD↓ Sell$1.1M
Aug 7, 2026RMD↓ Sell$1.0M
Jul 7, 2026RMD↓ Sell$1.1M
Jun 8, 2026RMD↓ Sell$968K
May 7, 2026RMD↓ Sell$1.0M
Apr 7, 2026RMD↓ Sell$1.1M
Feb 9, 2026RMD↓ Sell$1.4M
Jan 7, 2026RMD↓ Sell$1.2M
Dec 8, 2025RMD↓ Sell$1.3M
Nov 7, 2025RMD↓ Sell$2.0M
Oct 7, 2025RMD↓ Sell$2.3M
Sep 8, 2025RMD↓ Sell$2.2M
Aug 7, 2025RMD↓ Sell$2.2M
Jul 7, 2025RMD↓ Sell$2.1M
Jun 9, 2025RMD↓ Sell$2.0M
May 7, 2025RMD↓ Sell$1.9M
Apr 7, 2025RMD↓ Sell$1.7M
Mar 7, 2025RMD↓ Sell$1.8M
Feb 7, 2025RMD↓ Sell$1.9M
Nov 27, 2024RMD↓ Sell$499K
Nov 7, 2024RMD↓ Sell$3.6M
Oct 7, 2024RMD↓ Sell$3.4M
Sep 9, 2024RMD↓ Sell$3.6M
Aug 7, 2024RMD↓ Sell$3.1M
Jul 8, 2024RMD↓ Sell$2.8M
Jun 7, 2024RMD↓ Sell$3.1M
May 7, 2024RMD↓ Sell$3.2M
Nov 15, 2023RMD↓ Sell$863K
Oct 16, 2023RMD↓ Sell$798K
Sep 15, 2023RMD↓ Sell$831K
Aug 15, 2023RMD↓ Sell$1.0M
Jul 17, 2023RMD↓ Sell$1.3M
Jun 15, 2023RMD↓ Sell$1.2M
May 15, 2023RMD↓ Sell$1.3M
Apr 17, 2023RMD↓ Sell$1.3M
Mar 15, 2023RMD↓ Sell$1.2M
Feb 15, 2023RMD↓ Sell$1.2M
Jan 17, 2023RMD↓ Sell$1.3M
Dec 15, 2022RMD↓ Sell$1.2M
Nov 15, 2022RMD↓ Sell$1.3M
Nov 10, 2022RMD↓ Sell$1.1M
Oct 17, 2022RMD↓ Sell$1.2M
Sep 15, 2022RMD↓ Sell$1.3M
Aug 15, 2022RMD↓ Sell$1.4M
Jul 15, 2022RMD↓ Sell$1.3M
Jun 15, 2022RMD↓ Sell$1.1M
May 16, 2022RMD↓ Sell$1.1M
Apr 18, 2022RMD↓ Sell$1.3M
Mar 15, 2022RMD↓ Sell$1.4M
Feb 15, 2022RMD↓ Sell$1.3M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other RMD insiders

Open-market trades in the last 12 months

About Michael J. Farrell's insider trades

Michael J. Farrell is Chairman and CEO at Resmed (RMD). Since May 12, 2010, Michael has reported 1 open-market purchase worth $247K and 103 sales worth $111.0M on SEC Form 4. In the last 12 months: 10 sales ($12.2M).

Their filings also include option exercises (100 filings), grants and awards (99 filings), shares withheld for taxes (25 filings), gifts (6 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RMD insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.